At-Home Testing Market
The global At-Home Testing Market Size was valued at USD 16,663.94 million in 2021 and is estimated to surpass USD 45,582.24 million by 2031, growing at a CAGR of 10.5% from 2022 to 2031.
![at home testing market report]()
At-home tests also called self-tests or home-use tests are typically sold over the counter (OTC) and allow users to test self-collected specimens and interpret the results on their own without the help of trained health professionals. These types of tests differ from home-collection tests, which require users to collect samples at home, mail them to a laboratory or clinic for analysis, and obtain the results by telephone a few days later. Additionally, it has tools for continuously checking and managing diabetic patients' health. At-home tests can be taken in the comfort of own home and are extremely cost-effective. The procedures, packing, and instructions have all been made simpler to help people through the exam-taking process. There are several at-home test kits available, including those for HIV testing, pregnancy testing, diabetes testing, ovulation testing, coagulation monitoring test kits, and testing for infectious diseases including malaria, and others. Blood, urine, and oral fluid can all be used as samples for these quick tests that can be done at home.
Covid-19 Impact On At-Home Testing Market
The at-home testing market was slightly increased during the lockdown period owing to increased demand for self-testing kits. The COVID-19 pandemic increases the demand and production of at-home testing kits such as glucose monitoring devices, infectious diseases test kits, and other at-home testing kits, which increases the total net revenue of firms that deal in the manufacturing and distribution of testing and diagnostic devices. Therefore, to reduce the spread of the coronavirus, people are adopting more self-help testing kits due to several restrictions in place.
The market was analyzed qualitatively and quantitatively from 2020-2021. Most of the growth during this period was derived from the Asia-Pacific owing to the rise in prevalence of chronic diseases and the increase in the adoption of at-home testing kits in disease diagnosis at home, improving health awareness, rising disposable incomes, as well as the well-established presence of domestic companies in the region.
At-Home Testing Market Trends
The rise in technological advancement for the development of the latest at-home testing kits and devices and the rise in the prevalence of diabetes in increases the need for rapid testing kits creating an opportunity for the at-home testing market. In addition, growth of the at-home testing market is expected to be driven by the rise in awareness about the advantages offered by home-testing devices, and an increase in the demand for HIV testing kits, diabetes kits, and various others. Furthermore, the easy availability of self-testing kits at online stores and pharmacies without any prescription boosts the market growth. Moreover, the increase in the number of R&D activities in the field of at-home testing kits or medical devices enhanced healthcare services, and significant investments by the government to improve healthcare infrastructure has become a vital tool for small and large businesses globally, due to the rise in adoption for personalized self-assessing kits for the diagnosis of HIV disease. This is attributed to further support At-Home Testing Market Growth. As demand for At-home testing is not only limited to developed countries but is also being witnessed in developing countries, such as China, Brazil, and India, which fuel the growth of the market.
Furthermore, COVID-19 pandemic increases awareness among people regarding the use of self-testing kits. The COVID-19 pandemic increases the demand and production of at-home testing kits such as glucose monitoring devices, infectious diseases test kits, and other at-home testing kits, which increases the total net revenue of firms that deal in the manufacturing and distribution of testing and diagnostic devices. Therefore, to reduce the spread of the coronavirus, people are adopting more self-help testing kits due to several restrictions in place.
Furthermore, it has turned out to be a benefit for both hospitals and patients, as well as for pharmaceutical device manufacturers as hospitals are entirely focused on COVID-19 patients, and the patients can save hefty costs of doctor visits and medicine fees by self-testing some of the body vitals. It has become highly convenient for consumers as they can quickly know their test results at their fingertips. Thus, these factors are expected to create lucrative opportunities for the market to grow in the near future, providing profitable opportunities for key players post-COVID-19.
At-Home Testing Market Segment Overview
The at-home testing market is segmented on the basis of test type, age group distribution channel, and region. By test type, the market is segmented into glucose tests, infectious diseases test kits, pregnancy test kits, cholesterol test strips, drug of abuse test kits, coagulation monitoring test kits, and others. By age group, it is bifurcated into a pediatric, adult, and geriatric. By distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, and online pharmacies. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By Type
Based on test type, the market is segmented into glucose tests, infectious diseases test kits, pregnancy test kits, cholesterol test strips, drug of abuse test kits, coagulation monitoring test kits, and others. The glucose test kits segment dominated the global market in 2021 and is expected to remain dominant throughout the forecast period, owing to the rise in the prevalence of diabetes which increases the demand for home-based glucose test kits that boost the growth of the At-Home Testing Market Forecast.
By Age Group
By age group, at-home testing market is segregated into pediatric, adult, and geriatric. The adult segment dominated the global market in 2021 and is anticipated to continue this trend during the forecast period. This is attributed to the fact that with the increase in the age of a person, the chances of acquiring cancer and chronic diseases increase, which increases the demand for diagnostic kits or medical devices by adult age group patients hence propelling the At-Home Testing Market Size.
By Dsitribution Channel
By distribution channel, the at-home testing market is segregated into retail pharmacies, hospital pharmacies, and online pharmacies. The retail pharmacies segment has the largest At-Home Testing Market Share in 2021 and is anticipated to continue this trend during the forecast period. This is attributed to increasing investment in retail pharmacies and a shift towards more organized markets, and increased awareness of wellness and health, which increases the demand for at-home testing kits are the key factors that drive the growth of the market in upcoming years.
By Region
By region, the at-home testing market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a major share of the at-home testing market in 2021 and is expected to maintain its dominance during the forecast period. The presence of several major players, such as ACON Laboratories Inc, Cardinal Health Inc, Biomerieux SA, Abbott Laboratories, F. Hoffmann-La-Roche Ltd, B. Braun Melsungen AG, and the advancement in technology of at-home testing devices in the region drive the growth of the market. In addition, the surge in the adoption of self-testing kits owing to the pandemic, the rise in awareness about the importance of HIV diagnosis, increase in the prevalence of diabetes in the region, are the key factor that drives the growth of the market. Furthermore, product launches, mergers, collaborations, and acquisitions adopted by the key players in this region boost the growth of the market
Asia-Pacific is expected to grow at the highest rate during the forecast period. The At-Home Testing Industry growth in this region is attributable to the presence of pharmaceutical companies in the region as well as the rise in the geriatric population of the countries, such as China and India. Moreover, the rise in demand for self-testing kits owing to an increase in awareness amongst people, and advances in the medical device sector, drive the growth of the market. Furthermore, the Asia-Pacific region exhibits the largest medicine supply and the largest pharmaceutical industry with the availability of technologically advanced medical devices in abundance, which can be easily accessed by consumers. This, in turn, drives the growth of the market. Asia-Pacific offers profitable opportunities for key players operating in the at-home testing market, thereby registering the fastest growth rate during the forecast period, owing to the growing infrastructure of industries, rising disposable incomes, as well as the well-established presence of domestic companies in the region. In addition, increased technological innovations and heavy funding by government and private organizations, and increased investment by companies in R&D activities are expected to provide great opportunities for the growth of the market in this region.
Product Launch in the Market
- In July 2021, Abbott launched a COVID-19 home test kit in India for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms.
- In June 2022, Genes2Me Pvt. Ltd., one of the leading IVD solution manufacturer in India, launched CoviEasy self-test rapid antigen test kit for COVID-19 that is easy to use and give faster results in 10 minutes. Backed by an AI-driven mobile app, this IVD product delivers a high level of sensitivity and concordance of more than 98% accuracy.
- In November 2022 Israel-based start-up invented a novel pregnancy test kit, SalistickTM which is the first rapid saliva-based pregnancy test with a new and improved user experience and high accuracy for early pregnancy detection. The kit is based on revolutionary technology which detects the pregnancy hormone β-hCG in saliva.
Scope of At-Home Testing Market Report
| Report Metric |
Details |
| Report Name |
At-Home Testing Market |
| The market size in 2021 |
USD 16,663.94 Million |
| The revenue forecast in 2031 |
USD 45,582.24 Million |
| Growth Rate |
CCAGR of 10.5% |
| Market size available for years |
2022-2031 |
| Forecast units |
Value (USD) |
| Segments covered |
Type, Application, Industry, Regions |
| Report coverage |
Revenue & volume forecast, company share, competitive landscape, growth factors, and trends |
| Geographic regions covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Frequently Asked Questions About This Report
1. Do you provide chapter wise report data?
Ans. Yes, we do provide the option to buy chapters in a report. We also can customize the report based on your specific requirements.
2. How big is the At Home Testing Market?
Ans. The global air taxi market size is expected to be USD 817.50 Million by 2021, and is projected to reach USD 6.63 Billion by 2030, registering a CAGR of 26.2% from 2021 to 2030.
3. Does the report provides covid-19 impact analysis?
Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.
CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Market dynamics
- 3.4.1.Drivers
- 3.4.1.1. Increasing awareness about the importance of at-home testing kits
- 3.4.1.2. Rise in technological advancement
- 3.4.1.3. Easy availability of self-testing kits at pharmacies
- 3.4.2.Restraints
- 3.4.2.1. Inaccuracy of results by self-testing kits
- 3.4.3.Opportunities
- 3.4.3.1. High growth potential in developing economies
- 3.5.COVID-19 Impact Analysis on the market
CHAPTER 4: AT-HOME TESTING MARKET, BY TEST TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2. Glucose Test Kits
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
- 4.3. Infectious Diseases Test Kits
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country
- 4.4. Pregnancy Test Kits
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market share analysis by country
- 4.5. Cholesterol Test Strips
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market share analysis by country
- 4.6. Drugs of Abuse Test Kits
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market share analysis by country
- 4.7. Coagulation Monitoring Tests
- 4.7.1 Key market trends, growth factors and opportunities
- 4.7.2 Market size and forecast, by region
- 4.7.3 Market share analysis by country
- 4.8. Others
- 4.8.1 Key market trends, growth factors and opportunities
- 4.8.2 Market size and forecast, by region
- 4.8.3 Market share analysis by country
CHAPTER 5: AT-HOME TESTING MARKET, BY AGE GROUP
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2. Pediatric
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
- 5.3. Adult
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country
- 5.4. Geriatric
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market share analysis by country
CHAPTER 6: AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2. Retail Pharmacies
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market share analysis by country
- 6.3. Hospital Pharmacies
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market share analysis by country
- 6.4. Online Pharmacies
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market share analysis by country
CHAPTER 7: AT-HOME TESTING MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Test Type
- 7.2.3 North America Market size and forecast, by Age Group
- 7.2.4 North America Market size and forecast, by Distribution Channel
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Key market trends, growth factors and opportunities
- 7.2.5.1.2 Market size and forecast, by Test Type
- 7.2.5.1.3 Market size and forecast, by Age Group
- 7.2.5.1.4 Market size and forecast, by Distribution Channel
- 7.2.5.2 Canada
- 7.2.5.2.1 Key market trends, growth factors and opportunities
- 7.2.5.2.2 Market size and forecast, by Test Type
- 7.2.5.2.3 Market size and forecast, by Age Group
- 7.2.5.2.4 Market size and forecast, by Distribution Channel
- 7.2.5.3 Mexico
- 7.2.5.3.1 Key market trends, growth factors and opportunities
- 7.2.5.3.2 Market size and forecast, by Test Type
- 7.2.5.3.3 Market size and forecast, by Age Group
- 7.2.5.3.4 Market size and forecast, by Distribution Channel
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Test Type
- 7.3.3 Europe Market size and forecast, by Age Group
- 7.3.4 Europe Market size and forecast, by Distribution Channel
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Key market trends, growth factors and opportunities
- 7.3.5.1.2 Market size and forecast, by Test Type
- 7.3.5.1.3 Market size and forecast, by Age Group
- 7.3.5.1.4 Market size and forecast, by Distribution Channel
- 7.3.5.2 France
- 7.3.5.2.1 Key market trends, growth factors and opportunities
- 7.3.5.2.2 Market size and forecast, by Test Type
- 7.3.5.2.3 Market size and forecast, by Age Group
- 7.3.5.2.4 Market size and forecast, by Distribution Channel
- 7.3.5.3 UK
- 7.3.5.3.1 Key market trends, growth factors and opportunities
- 7.3.5.3.2 Market size and forecast, by Test Type
- 7.3.5.3.3 Market size and forecast, by Age Group
- 7.3.5.3.4 Market size and forecast, by Distribution Channel
- 7.3.5.4 Italy
- 7.3.5.4.1 Key market trends, growth factors and opportunities
- 7.3.5.4.2 Market size and forecast, by Test Type
- 7.3.5.4.3 Market size and forecast, by Age Group
- 7.3.5.4.4 Market size and forecast, by Distribution Channel
- 7.3.5.5 Spain
- 7.3.5.5.1 Key market trends, growth factors and opportunities
- 7.3.5.5.2 Market size and forecast, by Test Type
- 7.3.5.5.3 Market size and forecast, by Age Group
- 7.3.5.5.4 Market size and forecast, by Distribution Channel
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Key market trends, growth factors and opportunities
- 7.3.5.6.2 Market size and forecast, by Test Type
- 7.3.5.6.3 Market size and forecast, by Age Group
- 7.3.5.6.4 Market size and forecast, by Distribution Channel
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Test Type
- 7.4.3 Asia-Pacific Market size and forecast, by Age Group
- 7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Key market trends, growth factors and opportunities
- 7.4.5.1.2 Market size and forecast, by Test Type
- 7.4.5.1.3 Market size and forecast, by Age Group
- 7.4.5.1.4 Market size and forecast, by Distribution Channel
- 7.4.5.2 China
- 7.4.5.2.1 Key market trends, growth factors and opportunities
- 7.4.5.2.2 Market size and forecast, by Test Type
- 7.4.5.2.3 Market size and forecast, by Age Group
- 7.4.5.2.4 Market size and forecast, by Distribution Channel
- 7.4.5.3 Australia
- 7.4.5.3.1 Key market trends, growth factors and opportunities
- 7.4.5.3.2 Market size and forecast, by Test Type
- 7.4.5.3.3 Market size and forecast, by Age Group
- 7.4.5.3.4 Market size and forecast, by Distribution Channel
- 7.4.5.4 India
- 7.4.5.4.1 Key market trends, growth factors and opportunities
- 7.4.5.4.2 Market size and forecast, by Test Type
- 7.4.5.4.3 Market size and forecast, by Age Group
- 7.4.5.4.4 Market size and forecast, by Distribution Channel
- 7.4.5.5 South Korea
- 7.4.5.5.1 Key market trends, growth factors and opportunities
- 7.4.5.5.2 Market size and forecast, by Test Type
- 7.4.5.5.3 Market size and forecast, by Age Group
- 7.4.5.5.4 Market size and forecast, by Distribution Channel
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Key market trends, growth factors and opportunities
- 7.4.5.6.2 Market size and forecast, by Test Type
- 7.4.5.6.3 Market size and forecast, by Age Group
- 7.4.5.6.4 Market size and forecast, by Distribution Channel
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Test Type
- 7.5.3 LAMEA Market size and forecast, by Age Group
- 7.5.4 LAMEA Market size and forecast, by Distribution Channel
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Key market trends, growth factors and opportunities
- 7.5.5.1.2 Market size and forecast, by Test Type
- 7.5.5.1.3 Market size and forecast, by Age Group
- 7.5.5.1.4 Market size and forecast, by Distribution Channel
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Key market trends, growth factors and opportunities
- 7.5.5.2.2 Market size and forecast, by Test Type
- 7.5.5.2.3 Market size and forecast, by Age Group
- 7.5.5.2.4 Market size and forecast, by Distribution Channel
- 7.5.5.3 South Africa
- 7.5.5.3.1 Key market trends, growth factors and opportunities
- 7.5.5.3.2 Market size and forecast, by Test Type
- 7.5.5.3.3 Market size and forecast, by Age Group
- 7.5.5.3.4 Market size and forecast, by Distribution Channel
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Key market trends, growth factors and opportunities
- 7.5.5.4.2 Market size and forecast, by Test Type
- 7.5.5.4.3 Market size and forecast, by Age Group
- 7.5.5.4.4 Market size and forecast, by Distribution Channel
CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
- 9.1 ACON Laboratories, Inc
- 9.1.1 Company overview
- 9.1.2 Key Executives
- 9.1.3 Company snapshot
- 9.1.4 Operating business segments
- 9.1.5 Product portfolio
- 9.1.6 Business performance
- 9.1.7 Key strategic moves and developments
- 9.2 Quidel Corporation
- 9.2.1 Company overview
- 9.2.2 Key Executives
- 9.2.3 Company snapshot
- 9.2.4 Operating business segments
- 9.2.5 Product portfolio
- 9.2.6 Business performance
- 9.2.7 Key strategic moves and developments
- 9.3 Biomerieux SA
- 9.3.1 Company overview
- 9.3.2 Key Executives
- 9.3.3 Company snapshot
- 9.3.4 Operating business segments
- 9.3.5 Product portfolio
- 9.3.6 Business performance
- 9.3.7 Key strategic moves and developments
- 9.4 Everly Health, Inc
- 9.4.1 Company overview
- 9.4.2 Key Executives
- 9.4.3 Company snapshot
- 9.4.4 Operating business segments
- 9.4.5 Product portfolio
- 9.4.6 Business performance
- 9.4.7 Key strategic moves and developments
- 9.5 OraSure Technologies, Inc
- 9.5.1 Company overview
- 9.5.2 Key Executives
- 9.5.3 Company snapshot
- 9.5.4 Operating business segments
- 9.5.5 Product portfolio
- 9.5.6 Business performance
- 9.5.7 Key strategic moves and developments
- 9.6 PHC Holdings Corporation
- 9.6.1 Company overview
- 9.6.2 Key Executives
- 9.6.3 Company snapshot
- 9.6.4 Operating business segments
- 9.6.5 Product portfolio
- 9.6.6 Business performance
- 9.6.7 Key strategic moves and developments
- 9.7 B. Braun Melsungen AG
- 9.7.1 Company overview
- 9.7.2 Key Executives
- 9.7.3 Company snapshot
- 9.7.4 Operating business segments
- 9.7.5 Product portfolio
- 9.7.6 Business performance
- 9.7.7 Key strategic moves and developments
- 9.8 Cardinal Health Inc.
- 9.8.1 Company overview
- 9.8.2 Key Executives
- 9.8.3 Company snapshot
- 9.8.4 Operating business segments
- 9.8.5 Product portfolio
- 9.8.6 Business performance
- 9.8.7 Key strategic moves and developments
- 9.9 Abbott Laboratories
- 9.9.1 Company overview
- 9.9.2 Key Executives
- 9.9.3 Company snapshot
- 9.9.4 Operating business segments
- 9.9.5 Product portfolio
- 9.9.6 Business performance
- 9.9.7 Key strategic moves and developments
- 9.10 F. Hoffmann-La Roche Ltd.
- 9.10.1 Company overview
- 9.10.2 Key Executives
- 9.10.3 Company snapshot
- 9.10.4 Operating business segments
- 9.10.5 Product portfolio
- 9.10.6 Business performance
- 9.10.7 Key strategic moves and developments
